Eisai is a research-based human health care company which discovers, develops, packages, and markets pharmaceutical products with focus on neurology, oncology, Alzheimer's disease, epilepsy, and metabolic disorders. It offers a portfolio of tablets and injections for treatment of various diseases. The Company‘s areas of research and development focus include neuroscience, oncology, vascular, inflammatory and immunological reaction, and antibody-based programs.
Market capitalization (31-Oct-2017)
Closing share price (31-Oct-2017)